The University of Genoa is one of the largest universities in Italy. Located in Liguria on the Italian Riviera, the university was founded in 1481. It currently has about 40,000 students, 1,800 teaching and research staff and about 1,580 administrative staff. Wikipedia.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: GV-02-2016 | Award Amount: 9.56M | Year: 2016
The UPGRADE project aims to support the transition to a high efficient, cleaner and affordable powertrain technology systems, based on Spark Ignited GDI (Gasoline Direct Injection) approach, suitable for future Light Duty applications. The project also includes a deep analysis of the phenomenon of the formation of the nanoparticles in relationship to the engine design and its operating conditions and, with regard to the after-treatment solutions, the study and development of new Gasoline Particulate Filter (GPF) technologies. To increase the engine efficiency under Real Driving conditions, the following steps will be carried out: - address stoichiometric combustion approach on the small size engine and lean-burn combustion approach on the medium size one - study and develop the best combinations of technologies, including advanced VVA/VVT capabilities, advanced boosting system (including electrically assisted booster operations), EGR (Exhaust Gas Recirculation) and thermal management systems - Explore and implement advanced fuel injection (direct) and ignition system supported by new dedicated control strategies that will be integrated in the ECU (Engine Control Unit) software. In order to demonstrate the call overall targets (15% improvement on CO2 emissions based on the WLTP cycle and compliancy with post Euro 6 RDE standards) the project will see the realization of two full demonstrator vehicles: one B-segment vehicle, equipped with the small downsized stoichiometric engine, and one D/E vehicle equipped with the medium size lean-burn engine. The vehicle will be fully calibrated and assessed by independent testing, according to on road test procedures, using the available best representative PEMS (Portable Emission Measurement System) technology and considering also PN measurement below 23 nm diameter.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: MG-4.3-2015 | Award Amount: 11.43M | Year: 2016
Most maritime products are typically associated with large investments and are seldom built in large series. Where other modes of transport benefit from the economy of series production, this is not the case for maritime products which are typically designed to refined customer requirements increasingly determined by the need for high efficiency, flexibility and low environmental impact at a competitive price. Product design is thus subject to global trade-offs among traditional constraints (customer needs, technical requirements, cost) and new requirements (life-cycle, environmental impact, rules). One of the most important design objectives is to minimise total cost over the economic life cycle of the product, taking into account maintenance, refitting, renewal, manning, recycling, environmental footprint, etc. The trade-off among all these requirements must be assessed and evaluated in the first steps of the design process on the basis of customer / owner specifications. Advanced product design needs to adapt to profound, sometimes contradicting requirements and assure a flexible and optimised performance over the entire life-cycle for varying operational conditions. This calls for greatly improved design tools including multi-objective optimisation and finally virtual testing of the overall design and its components. HOLISHIP (HOLIstic optimisation of SHIP design and operation for life-cycle) addresses these urgent industry needs by the development of innovative design methodologies, integrating design requirements (technical constraints, performance indicators, life-cycle cost, environmental impact) at an early design stage and for the entire life-cycle in an integrated design environment. Design integration will be implemented in practice by the development of integrated design s/w platforms and demonstrated by digital mock-ups and industry led application studies on the design and performance of ships, marine equipment and maritime assets in general.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: SFS-10b-2015 | Award Amount: 5.41M | Year: 2016
The overarching goal of VIVALDI is to increase the sustainability and competitiveness of the European shellfish industry by improving the understanding of bivalve diseases and by developing innovative solutions and tools for the prevention, control and mitigation of the major pathogens affecting the main European farmed shellfish species: Pacific oyster (Crassostrea gigas), mussels (Mytilus edulis and M. galloprovincialis), European flat oyster (Ostrea edulis), clams (Venerupis philipinarum) and scallops (Pecten maximus ). The project addresses the most harmful pathogens affecting either one or more of these shellfish species: the virus OsHV-1, Vibrio species including V. aestuarianus, V. splendidus, V. harveyi and V. tapetis, as well as the parasite Bonamia ostreae. The project is committed to provide practical solutions based on the most advanced knowledge. VIVALDI will dissect the disease mechanisms associated with pathogen virulence and pathogenesis and host immune responses, develop in vivo and in vitro models, and apply omic approaches that will help the development of diagnostic tools and drugs against pathogen targets, and breeding programmes in a collaborative effort with industrial partners. The proposal will include a global shellfish health approach, recognising that cultured bivalves are often exposed to several pathogens simultaneously, and that disease outbreaks can be due to the combined effect of two or more pathogens. The proposal will also investigate advantages and risks of the used of disease-resistant selected animals in order to improve consumer confidence and safety. VIVALDI will be both multi- and trans-disciplinary. In order to cover both basic and applied levels from molecules to farm, the proposal will integrate partners with a broad range of complementary expertises in pathology and animal health, epidemiology, immunology, molecular biology, genetics, genomics and food safety.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: PHC-16-2015 | Award Amount: 6.00M | Year: 2016
AUTOSTEM will develop closed, scaleable and automated systems for therapeutic cell manufacture. The project vision is a donor-to-patient system where all aspects of processing, from tissue harvest to patient delivery are fully closed and aseptic. The process will involve new methods of biological cell selection from marrow, fat or other tissues, bioreactors to achieve scale and media formulations that are fully xeno-free. Process monitoring will utilise remote sensing and the automated retrieval of cells for microscopy, flow cytometry, karyotyping, differentiation or other tests. The final product will be a cryobag containing a specified cell dose, ready for thawing and clinical delivery. AUTOSTEM will be the factory of the future for therapeutic cell manufacturing. This system could ultimately be scaled for hospital-based use to produce autologous cells or at industrial scale for allogeneic therapy. It will achieve consistent cell production, minimise contamination, maximise scale and reduce cost of goods, thus enabling routine clinical use of cell therapies. The consortium will be a partnership of academic centres and industry with expertise across the disciplines relevant to the research and development goals. It will also include expertise in GMP and regulatory compliance and in healthcare economic analysis.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: ICT-20-2015 | Award Amount: 3.33M | Year: 2016
Whole-Body Interaction Learning for Dance Education WhoLoDance is aiming at both researching and innovating contemporary learning theories of embodied cognition and dance education, building on advances on neuroscience, pedagogical and learning theories, educational psychology together with new technologies in artificial intelligence and knowledge management. Dance is a diverse and heterogeneous practice and WhoLoDance will develop a protocol for the creation and/or selection of dance sequences drawn from different dance styles and appropriate for different teaching and learning modalities that can provide the base content for the capture, cataloguing and analysis of dance movement for the creation of different interactive and immersive learning tools. WhoLoDance will support learning the essential components of dance, enhancing movement skills, and creating solutions for supporting the composition, re-use, and distribution of interactive educational content and services, with assessment and feedback functionalities making use of immersive real-time tools to learn dance choreographies. WhoLoDance will explore smart learning environments for providing dance students with adaptive and personalised learning and assessment, through multi-modal/multi-sensory interaction technologies and advanced immersive real-time training interfaces. WhoLoDance will create and deliver the proof-of-concept of a motion capture repository of dance motions built in a method allowing interpolations, extrapolations and synthesis through similarity search to enable new and powerful dance teaching paradigms. Finally WhoLoDance aim is to create a digital environment that will provide dance educators and students, as well as creators (choreographers) the opportunity for capacity building and networking, bringing together practitioners from different physical spaces, and will allow them to communicate chorographical ideas and movement concepts online and work collaboratively.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: SC1-PM-14-2016 | Award Amount: 2.08M | Year: 2017
The groundbreaking objective of CARESSES is to build culturally competent care robots, able to autonomously re-configure their way of acting and speaking, when offering a service, to match the culture, customs and etiquette of the person they are assisting. By designing robots that are more sensitive to the users needs, CARESSES innovative solution will offer elderly clients a safe, reliable and intuitive system to foster their independence and autonomy, with a greater impact on quality of life, a reduced caregiver burden, and an improved efficiency and efficacy. The need for cultural competence has been deeply investigated in the Nursing literature. However, it has been totally neglected in Robotics. CARESSES stems from the consideration that cultural competence is crucial for care robots as it is for human caregivers. From the users perspective, a culturally appropriate behavior is key to improve acceptability; from the commercial perspective, it will open new avenues for marketing robots across different countries. CARESSES will adopt the following approach. First, we will study how to represent cultural models, how to use these models in sensing, planning and acting, and how to acquire them. Second, we will consider three (physically identical) replicas of a commercial robot on the market and integrate cultural models into them, by making them culturally competent. Third, we will test the three robots, customized for three different cultures, in the EU (two cultural groups) and Japan (one cultural group), on a number of elderly volunteers and their informal caregivers. Evaluation will be conducted through quantitative and qualitative investigation. To achieve its groundbreaking objective, CARESSES will involve a multidisciplinary team of EU and Japanese researchers with a background in Transcultural Nursing, AI, Robotics, Testing and evaluations of health-care technology, a worldwide leading company in Robotics and a network of Nursing care homes.
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: ICT-22-2016 | Award Amount: 2.45M | Year: 2017
The weDRAW project comes from the renewed neuroscientific understanding of the role of communication between sensory modalities during development: specific sensory systems have specific roles to learn specific concepts. Starting from these results, in weDRAW we will develop an multisensory technology and three serious games that will exploit the best modality for learning arithmetic and geometrical concepts. In particular weDRAW: - will provide the elements to the teacher to determine which is the best modality (visual, audio or haptic) to teach each specific concepts to the students; - will provide the technology to exploit the best sensory signal; - will permit to teach different concepts together. This will be possible by using a multisensory approach, that will open a new teaching/learning channel, personalized for each student, based on multisensory interactive technology (i.e., audio, tactile, motor and visual), including a serious game platform. - will show that it is possible to learn arithmetical concepts from multisensory rhythm exploration and music and geometrical concepts from body movement and multisensory drawing. - will permit a deeper learning of Science and Mathematics combined with Arts improving creative capacities of learners. Besides application to typical children, a major goal and output of this project consists of applying the proposed multisensory approach and technologies to two specific populations: visually impaired and dyslexic children. In particular, dyslexic children have problems with rhythm, whereas visually impaired children have problems with space and geometry. With weDRAW we expect to improve the spatial and temporal impairments of these two groups of children braking down social barriers.
Busca G.,University of Genoa
Chemical Reviews | Year: 2010
A scientific review informed about the characteristics of basic compounds and materials used in industrial and technological chemistry. The review emphasized on the the properties of liquid bases, the characterization, and use of solid bases. The contribution was intended to emphasize the linkage between the chemical knowledge of acid-base interactions and the engineering of chemical processes, along with their environmental impact. It also provided evidence of trends aimed at improving process safety and limiting environmental pollution when they were related to the increased use of solid basic materials.
Marcenaro E.,University of Genoa
Blood | Year: 2013
Natural killer (NK) cells may capture the CCR7 chemokine receptor from allogeneic CCR7(+) cells by trogocytosis and acquire migrating properties in response to lymph node chemokines. This event is negatively regulated by inhibitory killer Ig-like receptors (KIRs) and NKG2A. In this study, we analyzed the role of the HLA-C2-specific activating receptor KIR2DS1 in the process of CCR7 uptake by NK cells interacting with different allogeneic CCR7(+) cells. Co-incubation of KIR2DS1(+) fresh NK cells or NK-cell clones with HLA-C2(+) CCR7(+) lymphoblastoid cell lines resulted in increased CCR7 uptake. Remarkably, KIR2DS1 expression represented a major advantage for acquiring CCR7 from HLA-C2(+) allogeneic dendritic cells (DCs) and T-cell blasts. These findings have important implications in haploidentical hematopoietic stem cell transplantation in which donor-derived (alloreactive) KIR2DS1(+) NK cells, upon CCR7 acquisition, become capable of migrating toward lymph nodes, where they may kill patient DCs and T cells, preventing graft-versus-host and host-versus-graft reactions.
Agency: Cordis | Branch: H2020 | Program: IA | Phase: FTIPilot-1-2015 | Award Amount: 3.29M | Year: 2016
The GLAUrious project is promoting the novel External Automatic Glaucoma Laser (EAGLE) device with the goal of providing accessible first-line treatment for glaucoma. Glaucoma, a chronic disease causing progressive optic nerve degeneration, is the leading cause of irreversible blindness globally. Although incurable, disease progression is delayed by reducing intraocular pressure, thus preventing blindness. Some 64 million people worldwide suffer from glaucoma. Current first-line treatment requires daily eye drops, a strict regimen causing 50% patient dropout after 1 year. Laser treatment for glaucoma has been in use for many years. Its effect lasts for 25 years and is repeatable. This traditional 10-minute procedure, involving contact with the patients eye, requires the expertise of glaucoma specialists. Consequently, costs are high and accessibility to the general population is low. The novel EAGLE procedure is automated, non-invasive, non-contact, painless and user friendly1 second of treatment by one press of a button. This revolutionary cost-effective device could be safely used by the worlds 212,000 ophthalmologists, thus becoming a primary treatment for glaucoma, overcoming serious problems of eye drop non-compliance and effectively preventing disease deterioration. GLAUrious project aims to ease commercialization of the EAGLE device by securing clinical prototype validation, streamlining commercial production, optimizing component costs, disseminating to key opinion leaders and distributors, and refining commercial strategy. Validation of EAGLE will allow its commercialization within 3 years of project initiation, enabling penetration of the ophthalmic market and boosting of the industrial consortium partners (BEL, FLC and MCI). The multidisciplinary GLAUrious Consortium, with its five partners from four member states (Belgium, Germany, Italy, UK) and one associated state (Israel), incorporates three SMEs and two academic hospitals.